Multisite phosphorylation of doublecortin by cyclin-dependent kinase 5

被引:36
|
作者
Graham, ME [1 ]
Ruma-Haynes, P [1 ]
Capes-Davis, AG [1 ]
Dunn, JM [1 ]
Tan, TC [1 ]
Valova, VA [1 ]
Robinson, PJ [1 ]
Jeffrey, PL [1 ]
机构
[1] Childrens Med Res Inst, Wentworthville, NSW 2145, Australia
关键词
cyclin-dependent kinase 5 (cdk5); doublecortin (DCX); lissencephaly; MS; mutagenesis; phosphorylation;
D O I
10.1042/BJ20040324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Doublecortin (DCX) is a 40 kDa microtubule-associated protein required for normal neural migration and cortical layering during development. Mutations in the human DCX gene cause a disruption of cortical neuronal migration. Defects in cdk5 (cyclin-dependent kinase 5) also cause defects in neural migration and cortical layering. DCX is a substrate for cdk5 in vitro and in vivo and the major site of in vitro phosphorylation is Ser-297. We used a highly developed MS strategy to identify the cdk5 phosphorylation sites and determine the major and minor sites. Several phosphopeptides were identified from a tryptic digest of P-32-labelled, cdk5-phosphorylated DCX using a combination of off-line HPLC and matrix-assisted laser-desorption ionization-MS with alkaline phosphatase treatment. Tandem MS/MS enabled the identification of seven phosphorylation sites for cdk5. Monitoring of P-32 label indicated that there was one major site, Ser-28, at the N-terminus, and a major site, Ser-339, in the serine/proline-rich domain at the C-terminus. Five other sites, Ser-287, Thr-289, Ser-297, Thr-326 and Ser-332, were also found in the tail. Site-directed mutagenesis largely supported these findings. Single mutation of Ser-28 reduced but did not abolish phosphorylation. Double, rather than single, mutation for Ser-332 and Ser-339 was required to reduce overall phosphorylation, suggesting all interaction between these sites. Truncations of the tail produced a significant reduction in cdk5 phosphorylation of DCX. These results do not support Ser-297 as the major cdk5 phosphorylation site in DCX, but indicate that DCX is subject to complex multisite phosphorylation. This illustrates the importance of a well-developed MS strategy to identify phosphorylation sites.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 50 条
  • [41] Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7
    Lewis, Aurelia E.
    Rusten, Marte
    Hoivik, Erling A.
    Vikse, Elisabeth L.
    Hansson, Magnus L.
    Wallberg, Annika E.
    Bakke, Marit
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (01) : 91 - 104
  • [42] CYCLIN-DEPENDENT KINASE REGULATION
    LEES, E
    CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (06) : 773 - 780
  • [43] Phosphorylation of cyclin-dependent kinase 2 peptides enhances metal binding
    Baldwin, Graham S.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (01) : 151 - 154
  • [44] Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function
    Hume, Adam J.
    Finkel, Jonathan S.
    Kamil, Jeremy P.
    Coen, Donald M.
    Culbertson, Michael R.
    Kalejta, Robert F.
    SCIENCE, 2008, 320 (5877) : 797 - 799
  • [45] THE CYCLIN-DEPENDENT KINASE FAMILY
    HARLOW
    HUNTER
    NASMYTH
    HUNT
    KIRSCHNER
    BEACH
    PINES
    REED
    YANAGIDA
    LEHNER
    CIBA FOUNDATION SYMPOSIA, 1992, 170 : 205 - 208
  • [46] Identification of cyclin-dependent kinase phosphorylation sites in yeast phosphatidate phosphatase
    Choi, Hyeon-Son
    Morgan, Jeanelle M.
    Su, Wen-Min
    Han, Gil-Soo
    Carman, George M.
    FASEB JOURNAL, 2010, 24
  • [47] Cyclin-dependent kinase-mediated phosphorylation of yeast phosphatidate phosphatase
    Morgan, Jeanelle M.
    Carman, George M.
    FASEB JOURNAL, 2009, 23
  • [48] Cyclin-dependent kinase inhibitors
    Westwell, A
    DRUG DISCOVERY TODAY, 2001, 6 (09) : 491 - 491
  • [49] THE CYCLIN-DEPENDENT KINASE FAMILY
    MEYERSON, M
    FAHA, B
    SU, LK
    HARLOW, E
    TSAI, LH
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1991, 56 : 177 - 186
  • [50] Cyclin-dependent kinase inhibitors
    Dai, Y
    Grant, S
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) : 362 - 370